GEN Magazine

Volume 41, Issue No. 05, May 2021

May 2021 cover image

To feel as full of spirit as the month of May, wander through this issue of GEN and gather some of biotechnology’s most wondrous blooms: viral vectors, CRISPR screens, and microbiome-augmented cancer immunotherapies. In every case, practicality and beauty coincide because biotechnology is, as usual, working at the finest level, which is to say, the level of molecular mechanisms. Truly, as a poet once said, “nature is never spent; there lives the dearest freshness deep down things.” If readers need any more inspiration, they can discover how discoveries in viral evolution will help us manage pandemics, and how self-regulating biomanufacturing systems will yield novel biotherapeutics.

Browse the print magazine as a flipbook

Website Content from This Issue

Viral Evolution Insights Will Help Us Fight COVID-19

U.S. Centers for Disease Control and Prevention (CDC)

The Microbiome Gains Momentum in Cancer Immunotherapy

bacteria in a petri dish

Better Outfitted and Screened Viral Vectors Are Safer and More Effective

Adeno-associated virus (AAV)

CRISPR’s Rapid Rise Shakes Up Genome-Wide Screening


Bioprocessing Needs to Move Fast and NOT Break Things

Genentech’s biomanufacturing plant in Vacaville, CA

“Gut in a Dish” Facilitates Drug Development

To Mend Difficult Breaks, Try Porous Implants Treated with “Bone Paint”

David Stewart Inspects Package

Distributed Manufacturing Can Stabilize Biopharma Production

Drug Ampoules

Biosensors & Computers Help Optimize Bioprocessing Systems

clip from the Archives, MAY 1987, p16

Tecan Empowers Research, Helping Labs Realize Their Ambitions

Bioprocessing Technologies—Then and Now

Catalent Biologics’ state-of-the-art facility in Madison, WI

How the Detection of Viral RNA with LAMP Assays Could Increase Diagnostic Capacity to Fight the SARS-CoV-2 Pandemic

Protein Production and Antibody Characterization Services

Solid Phase Extraction Microplate Selection Guide

Human Plasma-Like Cell Culture Medium

Neuromatch Academy

AAAS Science and Technology Policy Fellowships



Doudna’s Scribe Rewrites CRISPR Drug Development with $100 Million Series B

Human Trial Finds Supplement Improves Age-Related Defects to Improve Cognition, Muscle Strength

Elderly exercise

New Genetic Mutation Discovered in People with Schizophrenia

Adult woman with split personality